Betydning av naturlige genvarianter for bivirkninger og effekt av kjemoterapi ved testikkelkreft
- Prosjektnummer
- 911502
- Ansvarlig person
- Olav Dahl
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Cancer
- Forskningsaktivitet
- 6. Treatment Evaluation
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.
Br J Cancer 2012 Nov;107(10):1684-91. Epub 2012 okt 25
PMID: 23099809
Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.
Int J Hyperthermia 2012;28(6):549-53. Epub 2012 jul 13
PMID: 22788973
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.
J Clin Oncol 2012 May;30(15):1755-62. Epub 2012 apr 2
PMID: 22473155
Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
Int J Radiat Oncol Biol Phys 2012 Jun;83(2):e173-80. Epub 2012 mar 19
PMID: 22436791
Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.
Br J Cancer 2012 Feb;106(4):756-62.
PMID: 22333708
Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys 2012 Jan;82(1):442-7. Epub 2010 okt 14
PMID: 20950963
The prognostic impact of tumor cell expression of estrogen receptor-a, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer.
Cancer 2012 Jan;118(1):157-63. Epub 2011 jun 28
PMID: 21713768
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Acta Oncol 2012 Feb;51(2):168-76. Epub 2011 des 19
PMID: 22175254
Testicular germ cell tumours - still many challenges.
Acta Oncol 2012 Feb;51(2):147-50.
PMID: 22263970
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
Hum Reprod 2012 May;27(5):1525-35. Epub 2012 mar 8
PMID: 22402210
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.
Br J Cancer 2012 Nov;107(11):1833-9.
PMID: 23169336
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
J Clin Oncol 2011 May;29(15):2032-9. Epub 2011 apr 11
PMID: 21482994
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
J Clin Oncol 2011 Feb;29(6):719-25. Epub 2011 jan 4
PMID: 21205748
Late side effects and quality of life after radiotherapy for rectal cancer.
Int J Radiat Oncol Biol Phys 2010 Mar;76(4):1005-11. Epub 2009 jun 18
PMID: 19540058
Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).
Strahlenther Onkol 2010 Jun;186(6):307-14. Epub 2010 apr 26
PMID: 20437013
Alternative cyclin D1 splice forms differentially regulate the DNA damage response.
Cancer Res 2010 Nov;70(21):8802-11. Epub 2010 okt 12
PMID: 20940395
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007.
Cancer Epidemiol 2010 Aug;34(4):359-67. Epub 2010 jun 2
PMID: 20627840
A study of coping in long-term testicular cancer survivors.
Psychol Health Med 2010 Mar;15(2):146-58.
PMID: 20391232
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Eur Urol 2010 Jul;58(1):134-40. Epub 2010 apr 2
PMID: 20395037
A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors.
J Cancer Surviv 2010 Sep;4(3):256-65. Epub 2010 jun 24
PMID: 20574815
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
J Clin Oncol 2010 Oct;28(30):4649-57. Epub 2010 sep 20
PMID: 20855830
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.
J Clin Oncol 2010 Nov;28(33):4906-11. Epub 2010 okt 18
PMID: 20956623
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
Ann Oncol 2010 Sep;21(9):1858-63. Epub 2010 feb 8
PMID: 20142410
Topographical distribution of choroidal naevi in the ocular fundus.
Eye (Lond) 2009 Aug;23(8):1685-90. Epub 2008 nov 28
PMID: 19039331
Topography of solitary congenital hypertrophy of the retinal pigment epithelium in the ocular fundus.
Acta Ophthalmol 2009 Nov;87(8):921-2.
PMID: 19604161
Rectal cancer with macroscopic peritoneal involvement--clinical challenges and consequences.
Colorectal Dis 2009 Oct;11(8):838-44. Epub 2008 okt 1
PMID: 19175632
Utilisation of specialist care in patients with incurable rectal cancer. a population-based study from Western Norway.
Acta Oncol 2009;48(3):377-84.
PMID: 19294541
Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer.
Eur J Cancer 2009 Sep;45(13):2383-90. Epub 2009 apr 6
PMID: 19356923
Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Acta Oncol 2009;48(3):368-76.
PMID: 19242829
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.
Br J Cancer 2009 Oct;101(8):1282-9. Epub 2009 sep 22
PMID: 19773751
Follow up your unexpected clinical observations!
Acta Oncol 2009;48(3):325-7.
PMID: 19294540
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor.
Int J Hyperthermia 2009 Feb;25(1):41-6.
PMID: 19219699
cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy.
Int J Radiat Oncol Biol Phys 2009 Dec;75(5):1562-9.
PMID: 19931738
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996.
Int J Hyperthermia 2009 Aug;25(5):323-34.
PMID: 19670088
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy.
Acta Oncol 2009;48(6):874-81.
PMID: 19488886
Fear of recurrence in long-term testicular cancer survivors.
Psychooncology 2009 Jun;18(6):580-8.
PMID: 18855944
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors.
Acta Oncol 2009;48(6):842-9.
PMID: 19412812
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
J Clin Oncol 2009 May;27(13):2122-8. Epub 2009 mar 23
PMID: 19307506
Pulmonary function in long-term survivors of testicular cancer.
J Clin Oncol 2009 Jun;27(17):2779-86. Epub 2009 mai 4
PMID: 19414680
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
J Natl Cancer Inst 2009 Dec;101(24):1682-95.
PMID: 19940282
Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues.
Eur J Pharmacol 2009 Dec;625(1-3):6-22. Epub 2009 okt 18
PMID: 19836383
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
Nat Genet 2009 Nov;41(11):1238-42. Epub 2009 okt 4
PMID: 19801978
Gene variants in sex hormone pathways and the risk of testicular cancer: A case-parent triad study in a Norwegian-Swedish popula
Human Reprod In Press 2012
Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av testikkelkreft.
Nasjonale faglige retningslinjer IS 1907, Helsedir. 2011, 1-109.
Testicular germ cell tumours - still new challenges.
Acta Oncol 51:147-50, 2012
High dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer.
Acta Oncol 51:168-76, 2012
253. L 2. Legemidler i behandlingen av kreftsykdommer.
Norsk legemiddelhåndbok for helsepersonell 2010. A. Vilberg (Ed). Foreningen for utgivelse av Legemiddelhåndboken, Oslo, 775-820, 2010
T2 Kreftsykdommer.
Norsk legemiddelhåndbok for helsepersonell 2010. A. Vilberg (Ed). Foreningen for utgivelse av Legemiddelhåndboken, Oslo, 103-125, 2010.
Medikamentell kreftbehandling. Cytostaticaboken 7. edition.
Bok. Farmakologisk Inst, Univ. i Oslo, Oslo 2009, pp 1-495
Kreftceller og kjemoterapi.
Medikamentell kreftbehandling. Cytostaticaboken. Farmakol. Inst, UiO, pp 12-37.
Medikamentell kreftbehandling.
Medikamentell kreftbehandling. Cytostaticaboken. Farmakol. Inst, UiO, pp 38-45.
Bivirkninger
Medikamentell kreftbehandling. Cytostaticaboken. Farmakol. Inst, UiO, pp 56-74.
Gastrointestinal kreft.
Medikamentell kreftbehandling. Cytostaticaboken. Farmakol. Inst, UiO, pp 363-375.
Kreft i nyre, ureter, urinblære og prostata.
Medikamentell kreftbehandling. Cytostaticaboken. Farmakol. Inst, UiO, pp 396-403.
Cancer testis.
Medikamentell kreftbehandling. Cytostaticaboken. Farmakol. Inst, UiO, pp 404-411.
Vox populi. Population-based outcome in testicular cancer
- Disputert:
- september 2011
- Hovedveileder:
- Olbjørn Klepp
Long-term effects in survivors of testicular cancer with emphasis on fertility and neurological side effects
- Disputert:
- november 2010
- Hovedveileder:
- Olav Dahl
Radiation therapy combined with hormone treatment for primary prostate cancer. Effects of radiation dose escalations and assessm
- Disputert:
- mai 2009
- Hovedveileder:
- Olav Dahl
Molecular and biological alterations in tumors after hyperthermia- Hyperthermia in addition to metronomic chemotherapy in rats a
- Disputert:
- desember 2009
- Hovedveileder:
- Øystein Fluge
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest